Company Financials
Abingdon Health plc Financials
Pound sterling
business
Abingdon Health plc Company Profile
Main Stock Listing
LSE: ABDX
Market Capitalization £13.3 Million as of July 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | -855.26 |
| Forward PE | 0.11 |
| Price to Sales TTM | £2.22 |
| Price to Book MRQ | £1625.00 |
| Enterprise to Revenue | 5.36 |
| Enterprise to EBITDA | -14.75 |
Financial Reports as of Jun. 30, 2023
Financials
| Fiscal Year Ends | 2023-06-30 |
| Most Recent Quarter | 2023-06-30 |
| Profit Margin | -41.82% |
| Operating Margin | -60.75% |
| Return on Assets TTM | -26.52% |
| Return on Equity TTM | -76.65% |
Income Statement
| Revenue TTM | £5,344,000 |
| Revenue per Share TTM | £0.02 |
| Quarterly Revenue Growth | 116.90% |
| Gross Profit TTM | £2,075,000 |
| EBITDA | £-1,943,000 |
| Net Income to Common TTM | £-2,235,000 |
| Diluted EPS TTM | £-0.01 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | £1,998,000 |
| Total Cash per Share MRQ | £0.01 |
| Total Debt MRQ | £ |
| Total Debt to Equity MRQ | 55.57 |
| Current Ratio MRQ | 1.79 |
| Book Value per Share MRQ | £0.01 |
Cash Flow
| Operating Cash Flow TTM | £-2,251,000 |
| Levered Free Cash Flow TTM | £-1,722,625 |
ABDX Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 121,717,000 |
| Float Shares | 67,671,806 |
| Avg 10 Volume | 137,223 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 58.36% |
| % Held by Institutions | 11.01% |
Stock Price Summary
| Beta | 0.13 |
| Fifty Two Week Low | £6.50 |
| Fifty Two Week High | £18.50 |
| Fifty Two Week Change | 2.56% |
| Day 50 MA | £9.21 |
| Day 200 MA | £9.75 |
Dividends and Splits
| Forward Annual Dividend Rate | £ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | £0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |